These tests include the immunohistochemical 4 (IHC4) protein test, 21-gene Recurrence Score (Oncotype DX), PAM50 intrinsic subtype (Prosigna), 12-gene Recurrence Score (EndoPredict), two-component Breast Cancer Index (based on the molecular grade index and HOXB13: IL17BR), and 70-gene signature (MammaPrint) [14,24,32,33,34,35,36,37,38]. This evidence concerns the gene HOXB13 and breast carcinoma.